Alnylam settles ‘inherently unpredictable’ patent litigation over Onpattro 19-Dec-2018 By Maggie Lynch Alnylam settled its patent litigation with Silence Therapeutics, after an ongoing litigation regarding patent infringement of Silence’s RNAi therapy.
Orchard Therapeutics plans to go public to raise $172m 17-Oct-2018 By Maggie Lynch Orchard will launch an IPO on the Nasdaq Stock Market to raise $172m to fund research and development.